Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3351136
Max Phase: Preclinical
Molecular Formula: C8H16N2O6
Molecular Weight: 236.22
Molecule Type: Small molecule
Associated Items:
ID: ALA3351136
Max Phase: Preclinical
Molecular Formula: C8H16N2O6
Molecular Weight: 236.22
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CNNC(=O)[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
Standard InChI: InChI=1S/C8H16N2O6/c1-9-10-8(15)7-6(14)5(13)4(12)3(2-11)16-7/h3-7,9,11-14H,2H2,1H3,(H,10,15)/t3-,4-,5+,6-,7+/m1/s1
Standard InChI Key: QVCQMBWHTQZQBT-ZFYZTMLRSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 236.22 | Molecular Weight (Monoisotopic): 236.1008 | AlogP: -3.92 | #Rotatable Bonds: 3 |
Polar Surface Area: 131.28 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 6 |
#RO5 Violations: 1 | HBA (Lipinski): 8 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 11.44 | CX Basic pKa: 3.67 | CX LogP: -3.76 | CX LogD: -3.76 |
Aromatic Rings: 0 | Heavy Atoms: 16 | QED Weighted: 0.28 | Np Likeness Score: 1.49 |
1. Pastor M, Cruciani G, Clementi S.. (1997) Smart region definition: a new way to improve the predictive ability and interpretability of three-dimensional quantitative structure-activity relationships., 40 (10): [PMID:9154968] [10.1021/jm9608016] |
2. Pan D, Liu J, Senese C, Hopfinger AJ, Tseng Y.. (2004) Characterization of a ligand-receptor binding event using receptor-dependent four-dimensional quantitative structure-activity relationship analysis., 47 (12): [PMID:15163189] [10.1021/jm030586a] |
3. Pastor M, Cruciani G, Watson KA.. (1997) A strategy for the incorporation of water molecules present in a ligand binding site into a three-dimensional quantitative structure--activity relationship analysis., 40 (25): [PMID:9406599] [10.1021/jm970273d] |
4. Gohlke H, Klebe G.. (2002) DrugScore meets CoMFA: adaptation of fields for molecular comparison (AFMoC) or how to tailor knowledge-based pair-potentials to a particular protein., 45 (19): [PMID:12213058] [10.1021/jm020808p] |
5. So SS, Karplus M.. (1997) Three-dimensional quantitative structure-activity relationships from molecular similarity matrices and genetic neural networks. 2. Applications., 40 (26): [PMID:9435905] [10.1021/jm970488n] |
6. Uddin R, Saeed M, Ul-Haq Z. (2013) Molecular docking- and genetic algorithm-based approaches to produce robust 3D-QSAR models, [10.1007/s00044-013-0812-0] |
Source(1):